1620 Investment Advisors, Inc. Biolife Solutions Inc Transaction History
1620 Investment Advisors, Inc.
- $126 Million
- Q4 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 2,295 shares of BLFS stock, worth $64,994. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,295
Previous 1,620
41.67%
Holding current value
$64,994
Previous $40,000
47.5%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BLFS
# of Institutions
188Shares Held
47.1MCall Options Held
4.3KPut Options Held
4.7K-
Casdin Capital, LLC New York, NY8.71MShares$247 Million19.45% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$155 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.24MShares$91.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$80.3 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.59MShares$45.1 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.21B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...